karppaus.info

Drawing on decades of research, Harvard psychiatrist Dr. Chris Palmer outlines a revolutionary new understanding that for the first time unites our existing knowledge about mental illness within a single framework: Mental disorders are metabolic disorders of the brain.
If you or someone you love is affected by mental illness, it might change your life.


We are in the midst of a global mental health crisis, and mental illnesses are on the rise. But what causes mental illness? And why are mental health problems so hard to treat? Drawing on decades of research, Harvard psychiatrist Dr. Chris Palmer outlines a revolutionary new understanding that for the first time unites our existing knowledge about mental illness within a single framework: Mental disorders are metabolic disorders of the brain.

Brain Energy explains this new understanding of mental illness in detail, from symptoms and risk factors to what is happening in brain cells. Palmer also sheds light on the new treatment pathways this theory opens up—which apply to all mental disorders, including anxiety, depression, ADHD, alcoholism, eating disorders, bipolar disorder, autism, and schizophrenia. Brain Energy pairs cutting-edge science with practical advice and strategies to help people reclaim their mental health.
This groundbreaking book reveals:

Why classifying mental disorders as “separate” conditions is misleading The clear connections between mental illness and disorders linked to metabolism, including diabetes, heart attacks, strokes, pain disorders, obesity, Alzheimer’s disease, and epilepsy The link between metabolism and every factor known to play a role in mental health, including genetics, inflammation, hormones, neurotransmitters, sleep, stress, and trauma The evidence that current mental health treatments, including both medications and therapies, likely work by affecting metabolism New treatments available today that readers can use to promote long-term healing …and much more

Itä-Suomen yliopiston tutkijoiden löytämien veren merkkiaineproteiinien avulla voisi olla mahdollista tunnistaa nuoria, joilla on riski sairastua mielenterveyden häiriöihin.

Arviolta 10–20 prosenttia nuorista kärsii mielenterveyden häiriöistä. Usein ne kuitenkin jäävät diagnosoimatta ja hoitamatta. Nuorten mielenterveyden häiriöiden varhaiseen tunnistamiseen kaivataankin kipeästi uusia keinoja.

Merkkiaineet, joiden avulla mielenterveyden häiriöitä voitaisiin ennakoida, voisivat tulevaisuudessa avata uusia mahdollisuuksia myös mielenterveysongelmien ehkäisyyn.

Breaking News from McLean Hospital & Harvard Medical School

Introducing the Metabolic and Mental Health Program

I am so thrilled and proud to announce the launch of the Metabolic and Mental Health Program at McLean Hospital, the flagship mental health hospital of Harvard Medical School and Mass General Brigham, Boston's leading health care system. This innovative program marks a significant stride in mental health care, integrating metabolic insights into the treatment of mental health disorders.

Our Ambitious Goal: To transform the mental health field by investigating the metabolic drivers of mental illness and developing and studying metabolic interventions to improve outcomes for people with mental health conditions.

Key Initiatives:
Metabolic and Mental Health Consultation Service: A new clinical service with a focus on metabolic health assessments and treatment strategies, offered by a multi-disciplinary team, including a psychiatrist, dietitian, and health and wellness coach.

Groundbreaking Research: Conducting original studies on the metabolic drivers of mental disorders to improve patient outcomes.

Educational Outreach: Advancing the metabolic theory of mental illness through scholarly publications and public education.

Training for Clinicians: Collaborating with McLean Hospital’s Department of Postgraduate and Continuing Education and Harvard Medical School’s Office for External Education to offer comprehensive trainings.

An exciting new field, metabolic psychiatry, is finding that a ketogenic diet can reverse mental health conditions including depression, bipolar, schizophrenia, eating disorders. These are stunning findings.
Kudos to @NPR @NPRHealth for reporting on this. @ChrisPalmerMD @GeorgiaEdeMD @janellison @Metabolic_Mind
npr.org/sections/healt…

Medical revolutions often start with anecdotes: A physician stumbles on a therapy for an intractable disorder and publishes a “case report.” Other such reports follow, and if the therapy continues to work, then it’s time for clinical trials, weighing any benefits against potential harms as well as the existing standard of care. If the intervention is a drug, the pharmaceutical industry will cover the expenses. If it’s a diet, we hope to have benefactors.

The ketogenic diet for serious mental illness is now on that track, and we’re fascinated to see how far it goes. First there were several case studies¹ showing that depression and schizophrenia could be reversed using a ketogenic diet; then, in 2022, a pilot trial with very promising results. Now, Harvard’s McLean Hospital has announced that it will be running a clinical trial testing the effect of ketogenic diet therapy on bipolar or schizoaffective disorder. Some 50 newly diagnosed patients will be randomized to drug therapy plus a ketogenic diet or drug therapy and a diet based on the Dietary Guidelines for Americans. The patients will be tracked for 12 weeks to see how the diets affect their metabolism and, of course, their mental state. Some $2 million in funding for the trial is coming from the Baszucki Family Foundation, an entity created by the Roblocks founder David Baszucki and his wife, Jan, whose son with bipolar disorder was considered “treatment resistant” for years until a ketogenic diet was recommended–and, amazingly, reversed his condition. This story was the subject of a lengthy Today Show segment this week. Details of the new trial can be found on Clinicaltrials.gov.